Therapeutic Asset Ratings
297 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Fludarabine
Childhood Diffuse Large Cell Lymphoma
Roswell Park Cancer Institute
P3
BBB
(73)
Fludarabine
Recurrent Small Lymphocytic Lymphoma
Roswell Park Cancer Institute
P3
BBB
(73)
Fludarabine
Recurrent Grade 1 Follicular Lymphoma
Roswell Park Cancer Institute
P3
BB
(71)
Fludarabine
Recurrent Mantle Cell Lymphoma
Roswell Park Cancer Institute
P3
BB
(71)
FLUTICASONE
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute
P3
BB
(70)
Cyclophosphamide
Ovarian Serous Adenocarcinoma
Roswell Park Cancer Institute
P2
BB
(70)
Inno-206
HER2/Neu Negative
Roswell Park Cancer Institute
P3
BB
(69)
Cyclophosphamide
Chronic Leukemia
Roswell Park Cancer Institute
P4
BB
(68)
Cyclophosphamide
Hepatocellular Carcinoma
Roswell Park Cancer Institute
P3
BB
(68)
Inno-206
Estrogen Receptor Negative
Roswell Park Cancer Institute
P3
BB
(68)
Inno-206
Progesterone Receptor Negative
Roswell Park Cancer Institute
P3
BB
(68)
INTERFERON ALFA-2B
Recurrent Melanoma
Roswell Park Cancer Institute
P3
BB
(68)
Montanide Isa 51
Lung Non-Small Cell Carcinoma
Roswell Park Cancer Institute
P3
BB
(68)
Pembrolizumab
Recurrent Primary Peritoneal Carcinoma
Roswell Park Cancer Institute
P3
BB
(68)
Sargramostim
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute
P3
BB
(68)
Epirubicin
Recurrent Fallopian Tube Carcinoma
Roswell Park Cancer Institute
P2
BB
(68)
Pembrolizumab
Recurrent Fallopian Tube Carcinoma
Roswell Park Cancer Institute
P2
BB
(68)
Epirubicin
Diffuse Large B Cell Lymphoma
Roswell Park Cancer Institute
P4
BB
(67)
Epirubicin
Primary Peritoneal Carcinoma
Roswell Park Cancer Institute
P3
BB
(67)
CIS-DIAMMINEDICHLOROPLATINUM II
Sarcoma
Roswell Park Cancer Institute
P2
BB
(67)
Pembrolizumab
High Grade Ovarian Serous Adenocarcinoma
Roswell Park Cancer Institute
P2
BB
(67)
Rapamycin
Adult Acute Lymphoblastic Leukemia in Remission
Roswell Park Cancer Institute
P2
BB
(67)
(+)-VINCRISTINE
Blasts 5 Percent or More of Bone Marrow Nucleated Cells
Roswell Park Cancer Institute
P2
BB
(67)
Decitabine
Adult Acute Monoblastic Leukemia (M5a)
Roswell Park Cancer Institute
P3
BB
(66)
Decitabine
Adult Acute Monocytic Leukemia (M5b)
Roswell Park Cancer Institute
P3
BB
(66)
Showing 1 to 25 of 297 assets
Previous
Page 1 of 12
Next